Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed)
The summary for the Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed): The goal of this notice of funding opportunity (NOFO) is to continue to provide operations support to the National Biocontainment Laboratories at the University of Texas Medical Branch (UTMB) in Galveston, Texas and Boston University in Boston, Massachusetts. Operations support is provided in the following areas: facility maintenance and operations; biosecurity; environmental health and safety regulations and requirements; regulatory compliance; and specialized research support services. The NBLs serve as a national resource for efforts in conducting pre-clinical and laboratory (in vitro and in vivo) research and testing on hazardous biological agents in support of NIAIDs biodefense and emerging infectious diseases research efforts. Additionally, in times of a national biodefense or emerging infectious disease (EID) emergency, the NBLs may be expected to rapidly realign their activities to assist response efforts within the US under the direction of NIAID.
| Federal Grant Title: | Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed) |
| Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-AI-25-013 |
| Type of Funding: | Cooperative Agreement |
| CFDA Numbers: | 93.855 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | November 7th, 2025 |
| Original Application Deadline: | November 7th, 2025 |
| Posted Date: | September 18th, 2025 |
| Creation Date: | September 18th, 2025 |
| Archive Date: | December 13th, 2025 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
| Last Updated: | September 18th, 2025 |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education - Private institutions of higher education
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Eligible Organizations: The University of Texas Medical Branch at Galveston, TX and Boston University, Boston, MA Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-25-013.html
- Grant Announcement Contact
- NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)
- • Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)
- • Influenza Transmission Research Consortium (P01 Clinical Trial Optional)
- • Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed)
- • Partnerships for Development of Vaccines to Prevent Mycobacterium tuberculosis Infection a...
- • Center for HIV/AIDS Vaccine Immunology (CHAVI)
- • Genomics of Transplantation Cooperative Research Program
- • Asthma and Allergic Diseases Cooperative Research Centers
- More Grants from the National Institutes of Health
- • Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechan...
- • Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)
- • Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research...
- • NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial N...
- • Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial N...
